[Vertigo attacks -- current therapy].
Helling
K
K
Charité Campus Benjamin Franklin (CBF), Universitätsmedizin Berlin. kai.helling@charite.de
Scherer
H
H
D000086:Acetazolamide / Q000008:administration & dosage / Q000009:adverse effects; D000328:Adult; D000368:Aged; D001621:Betahistine / Q000008:administration & dosage / Q000009:adverse effects; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D004432:Ear, Middle / Q000187:drug effects / Q000503:physiopathology; D005839:Gentamicins / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007267:Injections; D008575:Meniere Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D026201:Musculoskeletal Manipulations; D010037:Otolithic Membrane / Q000503:physiopathology; D026741:Physical Therapy Modalities; D010852:Picrotoxin / Q000008:administration & dosage* / Q000009:adverse effects; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D012648:Self Care; D013469:Sulpiride / Q000008:administration & dosage / Q000009:adverse effects; D014717:Vertigo / Q000188:drug therapy* / Q000503:physiopathology; D020338:Vestibular Neuronitis / Q000188:drug therapy* / Q000503:physiopathology
D000086:Acetazolamide; D001621:Betahistine; D003907:Dexamethasone; D005839:Gentamicins; D010852:Picrotoxin; D011241:Prednisone; D013469:Sulpiride